January 1963

Plasma Histamine During Cardiopulmonary Bypass in Man

Author Affiliations

From the Department of Surgery and the Center for Cardiovascular Research, St. Louis University School of Medicine.

Arch Surg. 1963;86(1):138-142. doi:10.1001/archsurg.1963.01310070140018

Many factors influence the adequacy and distribution of systemic blood flow during extracorporeal circulation.1 The liberation of endogenous vasoactive substances may alter the character of the perfusion or modify the function of various organs. Even during perfusions with conditions maintained within "physiologic" limits, there may be alterations in blood catecholamine levels.2

Another vasoactive amine which may be liberated from intracellular sites by a variety of interventions is histamine. This substance has many pharmacologic properties which might alter the status of an animal during cardiopulmonary bypass.3 It may increase vascular permeability, modify ganglionic transmission in the sympathetic nervous system, alter regional flow by relaxation of vascular smooth muscle, or affect the heart directly. In addition it may cause bronchiolar constriction; this could have a bearing on the pulmonary complications that may follow cardiopulmonary bypass.

Because of these relevant possibilities, it seemed desirable to study plasma histamine levels during

First Page Preview View Large
First page PDF preview
First page PDF preview